2009
DOI: 10.2967/jnumed.109.061879
|View full text |Cite
|
Sign up to set email alerts
|

Retention of the Radiotracers 64Cu-ATSM and 64Cu-PTSM in Human and Murine Tumors Is Influenced by MDR1 Protein Expression

Abstract: Tumor hypoxia is often associated with resistance to chemotherapy. Multidrug resistance type 1 (MDR1) protein is a member of the adenosine triphosphate binding cassette (ABC) proteins, some of which are involved in the multidrug resistance (MDR) phenotype in tumors. Many studies have focused on the role of these proteins in modulating drug resistance, but their effect on retention of imaging agents is less well studied. To study the role of MDR1 expression on the accumulation of 64 Cu-diacetyl-bis(N4-methylthi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
31
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 40 publications
(31 citation statements)
references
References 30 publications
(40 reference statements)
0
31
0
Order By: Relevance
“…The correlation of intratumoral 64 Cu distribution with nitroimidazole-based markers was also variable and time-dependent (12)(13)(14). This suggests that the strong correlation between retention of radiocopper from Cu-ATSM and poor treatment outcome observed in clinical studies may be governed by additional mechanisms other than tumor pO 2 (11,(15)(16)(17).…”
mentioning
confidence: 80%
“…The correlation of intratumoral 64 Cu distribution with nitroimidazole-based markers was also variable and time-dependent (12)(13)(14). This suggests that the strong correlation between retention of radiocopper from Cu-ATSM and poor treatment outcome observed in clinical studies may be governed by additional mechanisms other than tumor pO 2 (11,(15)(16)(17).…”
mentioning
confidence: 80%
“…This tracer shows favorable kinetics with rapid uptake in hypoxic tissue and fast clearance from normoxic tissues, enabling imaging within 30 min after injection [66,67] . However, the exact uptake mechanism of [Cu]ATSM is still under debate [63,68,69] and several preclinical studies have shown that [Cu]ATSM uptake depends on tumor type and other characteristics than hypoxia alone [70][71][72][73][74][75][76] .…”
Section: F]fmisomentioning
confidence: 99%
“…In hypoxic cells, reoxidation occurs at a slower rate, leaving enough time for dissociation of the unstable [ 64 Cu-ATSM] 2 . The radioactive copper isotope then becomes part of the intracellular copper pool, and some studies have indicated that there also appears to be an efflux of either radiolabeled 64 Cu-ATSM or copper from cancer cells (30)(31)(32). Moreover, studies of copper metabolism using 64 CuCl 2 PET in tumor xenograft mouse models have reported high tumor accumulation in some tissue types (33,34).…”
mentioning
confidence: 99%